Avanir Shares Rise on Zenvia Trial Data
Avanir, a pharmaceutical company developing treatments for CNS disorders and inflammatory diseases, announced that its multiple sclerosis drug Zenvia met its goal in a six-month clinical trial.
novimmune
DATATRAK Awarded Phase III Trial With Top 20 Pharma Company
DATATRAK International, a provider of technical support systems for clinical studies, has been awarded a Phase III clinical trial by the European division of a Global Top 20 pharmaceutical company.